Human Trial Compares Kratom Extract Exposure With Leaf Powder and Tea
A randomized, double-blind, placebo-controlled trial in healthy adults has characterized how the body handles mitragynine and its metabolite 7-hydroxymitragynine after encapsulated kratom extract, according to a study in the Journal of Analytical Toxicology. Researchers including Marilyn Huestis gave participants single doses, then 15 consecutive daily